{"id":"glipizide-gits","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Hypoglycemia"},{"rate":"5-10%","effect":"Nausea"},{"rate":"5-10%","effect":"Diarrhea"}]},"_chembl":{"chemblId":"CHEMBL1073","moleculeType":"Small molecule","molecularWeight":"445.55"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Glipizide acts as a sulfonylurea receptor agonist, stimulating insulin release from pancreatic beta cells.","oneSentence":"Sulfonylurea receptor agonist","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T02:38:36.548Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 2 diabetes"}]},"trialDetails":[{"nctId":"NCT00550329","phase":"","title":"Bioequivalence Study Of Glucotrol XL 2.5 Mg Tablets","status":"COMPLETED","sponsor":"Pfizer","startDate":"2007-10","conditions":"Diabetes Mellitus, Non-Insulin-Dependent, Hyperglycemia","enrollment":32}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":26,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"Glipizide GITS","genericName":"Glipizide GITS","companyName":"Pfizer","companyId":"pfizer","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Sulfonylurea receptor agonist Used for Type 2 diabetes.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}